InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.15
(
1.17%
)
US TECH 100
18,138.40
(
1.69%
)
Dow Jones
39,908.00
(
0.88%
)
Brent Oil
82.86
(
0.24%
)
Bitcoin
66,011.12
(
-0.38%
)
Post# of 251828
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119639
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 116047

Tuesday, 04/16/2019 11:30:54 AM

Tuesday, April 16, 2019 11:30:54 AM

Post# of 251828
OPHT—>ISEE (Iveric Bio) at the open tomorrow:

https://www.businesswire.com/news/home/20190416005282/en

“We are excited about our re-branding and corporate name change reflecting our transition to a gene therapy focused company developing treatments for patients with orphan inherited retinal diseases,” stated Glenn P. Sblendorio, Chief Executive Officer and President of IVERIC bio.

In other words, they don’t want investors to be reminded of the Fovista failures.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up